Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
about
Advances in the treatment of testicular cancerPostchemotherapy surgery for germ cell tumors--what have we learned in 35 years?Canadian consensus guidelines for the management of testicular germ cell cancer.Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors.The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: current concepts and controversiesRetroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.Postchemotherapy retroperitoneal lymph node dissection for testis cancer.Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.Surgical removal of retroperitoneal tumors after chemotherapy treated testicular tumors.Management of stage I testicular germ cell tumours.Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer.Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update.[When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?]The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor.
P2860
Q26773626-C76F4281-96E6-4181-946B-7C10675EBB28Q33577850-E2479139-5003-4F11-B388-134479B1AD44Q33753786-F0E2B2E7-FD13-45CC-8A69-EF2111A43DAAQ35076383-0E741B7C-EC26-4259-9156-2BB08A9BF28BQ37714115-008BB7F4-D3D1-441A-81ED-54D56103D7A0Q37763854-7CE16DA0-CD78-4BA0-B53A-EFC534218A1CQ37808289-F5D5E96C-6C64-4284-B431-597BF9854C91Q37821901-10ACA164-6861-4108-BC12-7BE428878135Q38125927-4DF157D2-2B16-4817-9955-E63FD73B3679Q38256215-0E1234D5-380E-4379-8F95-AC75E7C1FCE6Q38952121-45B6762A-B7C8-43EE-8EE3-E2EF4D280D85Q39308370-40E866C3-DBB4-4C79-98AB-56F3E314DAB2Q42239675-00AA07E6-2B40-43AD-A440-C9BCA474B026Q42249126-C1D2F73A-F91F-4153-AD20-223F82D1313EQ43223621-626B03DA-487A-49A4-8C4C-58E228326F41Q46728739-5A8EC3E4-32FD-4482-AD29-5E80BD92CC3DQ48122733-413D47A9-9450-4CF6-8C88-4061DA701853Q52673854-B53ADAFA-E4B1-4D05-ACFD-4111554B0321Q55120388-7A7966D4-8360-4CC7-B351-348EBEA34ABC
P2860
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Is full bilateral retroperiton ...... stchemotherapy residual tumor?
@en
type
label
Is full bilateral retroperiton ...... stchemotherapy residual tumor?
@en
prefLabel
Is full bilateral retroperiton ...... stchemotherapy residual tumor?
@en
P2093
P356
P1433
P1476
Is full bilateral retroperiton ...... stchemotherapy residual tumor?
@en
P2093
John P Donohue
Lawrence H Einhorn
Richard Bihrle
Richard S Foster
Stephen D W Beck
P304
P356
10.1002/CNCR.22898
P407
P577
2007-09-01T00:00:00Z